Edition:
India

Becton Dickinson and Co (BDX.N)

BDX.N on New York Stock Exchange

218.94USD
13 Dec 2017
Change (% chg)

$-0.05 (-0.02%)
Prev Close
$218.99
Open
$218.76
Day's High
$220.57
Day's Low
$218.48
Volume
277,753
Avg. Vol
292,319
52-wk High
$229.47
52-wk Low
$161.72

Summary

Name Age Since Current Position

Vincent Forlenza

64 2017 Chairman of the Board, Chief Executive Officer

Thomas Polen

44 2017 President

Christopher Reidy

60 2013 Chief Financial Officer, Executive Vice President, Chief Administrative Officer

Linda Tharby

49 2016 Chief Human Resource Officer, Executive Vice President

Nabil Shabshab

52 2011 Executive Vice President - Strategic Planning Chief Marketing Officer

Alexandre Conroy

54 2012 Executive Vice President and President, Europe, EMA

James Lim

53 2012 Executive Vice President and President, Greater Asia

Alberto Mas

56 2016 Executive Vice President and President - Life Sciences Segment

Ellen Strahlman

60 2013 Executive Vice President, Research and Development and Chief Medical Officer

Basil Anderson

71 2004 Independent Director

Catherine Burzik

66 2013 Independent Director

R. Andrew Eckert

55 2016 Independent Director

Claire Fraser

61 2006 Independent Director

Christopher Ian Jones

61 2010 Independent Director

Marshall Larsen

68 2007 Independent Director

Gary Mecklenburg

70 2004 Independent Director

David Melcher

62 2017 Independent Director

James Orr

71 2000 Independent Director

Willard Overlock

71 1999 Independent Director

Claire Pomeroy

61 2014 Independent Director

Rebecca Rimel

66 2012 Independent Director

Timothy Ring

59 2017 Independent Director

Bertram Scott

66 2002 Independent Director

Monique Dolecki

IR Contact Officer

Biographies

Name Description

Vincent Forlenza

Mr. Vincent A. Forlenza is a Chairman of the Board, Chief Executive Officer of Becton, Dickinson and Company. During his more than 35-year career with BD, Mr. Forlenza has held a number of executive leadership positions globally, in the United States and in Europe. Mr. Forlenza was named President in January 2009, assumed additional responsibility as Chief Operating Officer in July 2010, and became Chief Executive Officer in October 2011 and Chairman of the Board in July 2012. Previous appointments include leadership roles as Senior Vice President, Technology, Strategy and Development; President of BD Biosciences; and Executive Vice President and President, BD Diagnostics. Mr. Forlenza is the former Chairman of the Advanced Medical Technology Association (AdvaMed) Board of Directors. As chairman, he significantly advanced the association’s innovation agenda, collaborating with policymakers and industry partners to reinvigorate the innovation ecosystem and promote the value of medical technology in extending and improving patients’ lives, enhancing population health and supporting economically sound health systems. He served on both the AdvaMed Board and its Executive Committee for seven years and is also the past chair of the association’s Board Committee on Technology and Regulation. In addition, he served as Chairman of the Board for AdvaMedDx, a division of AdvaMed focused on the unique needs and issues facing diagnostics manufacturers. Mr. Forlenza currently serves on the Board of Trustees at The Valley Health Systems and previously served as Chairman of The Valley Hospital. He is a past member of the Advisory Board for the P.C. Rossin College of Engineering and Applied Sciences at Lehigh University, where he also served as a member of the Board of Trustees. Mr. Forlenza obtained his bachelor’s degree in chemical engineering from Lehigh University in 1975 and his MBA from Wharton Graduate School, University of Pennsylvania in 1980.

Thomas Polen

Mr. Thomas E. Polen is President of the Company. He was Prior to Group President from October 2013 to October 2014; and Worldwide President - BD Diagnostic Systems from October 2010 to October 2013.

Christopher Reidy

Mr. Christopher R. Reidy is Chief Financial Officer, Executive Vice President, Chief Administrative Officer of the company. He joins BD from ADP Corporation, where he served as Corporate Vice President and CFO for six years. Prior to ADP, Mr. Reidy’s more than 30 years of experience includes serving as CFO at NBA Properties, Inc.; Vice President, Controller & Chief Accounting Officer and division CFO roles at AT&T Corporation; and Audit Partner at Deloitte & Touche. Mr. Reidy, a Certified Public Accountant, earned his MBA from Harvard University and his B.S. in accounting from St. Francis College.

Linda Tharby

Ms. Linda M. Tharby is Chief Human Resource Officer, Executive Vice President of the company. She was President - Life Sciences Segment from October 2014 to October 2016; Group President from October 2013 to October 2014; and prior thereto, Worldwide President - BD Medical, Diabetes Care.

Nabil Shabshab

Mr. Nabil Shabshab is an Executive Vice President - Strategic Planning and Chief Marketing Officer of the Company.

Alexandre Conroy

Mr. Alexandre Conroy is an Executive Vice President and President - Europe EMA of the Company. He was prior thereto, President, Western Europe.

James Lim

Mr. James Lim is an Executive Vice President and President, Greater Asia of the Company. He served as Vice President and General Manager, Central Asia Pacific and Operations Since June 2012.

Alberto Mas

Mr. Alberto Mas is an Executive Vice President and President - Life Sciences Segment of the company. He was Worldwide President - Life Sciences, Diagnostic Systems from October 2013 to October 2016; and Worldwide President - BD Biosciences from October 2011 to October 2013.

Ellen Strahlman

Dr. Ellen R. Strahlman, M.D. is no longer as an Executive Vice President, Research and Development and Chief Medical Officer of the Company, effective December 31, 2017. She is Senior Vice President, Office of the CEO and Global Head, Neglected Tropical Diseases of GlaxoSmithKline from March 2012 to May 2012, and prior thereto, Chief Medical Officer of GlaxoSmithKline plc.

Basil Anderson

Mr. Basil L. Anderson is Independent Director of the Company. He served as Vice Chairman of Staples, Inc., a supplier of office products. Prior thereto, he was Executive Vice President – Finance and Chief Financial Officer of Campbell Soup Company. Mr. Anderson also is a director of Hasbro, Inc. and Moody’s Corporation Mr. Anderson has an extensive business and financial background as both an operating executive and as a chief financial officer of a major multinational public company. His experience includes strategic, business and financial planning and operations; international operations; and service as a director for public companies in different industries.

Catherine Burzik

Ms. Catherine M. Burzik is Independent Director of the Company. She served as President and Chief Executive Officer of Kinetic Concepts, Inc., a medical device company specializing in the fields of woundcare and regenerative medicine. Prior thereto, she was President of Applied Biosystems and President of Ortho-Clinical Diagnostics, Inc., a Johnson & Johnson company. Ms. Burzik also is a director of Haemonetics Corporation and General Partner of Targeted Technology Fund II, LP. She was formerly a director of Allscripts Healthcare Solutions, Inc.Ms. Burzik is a seasoned executive in the healthcare industry, having led major medical device, diagnostic, diagnostic imaging and life sciences businesses. She contributes strong strategic and leadership expertise, and extensive knowledge of the global healthcare field.

R. Andrew Eckert

Mr. R. Andrew Eckert is Independent Director of the Company. He served as the Chief Executive Officer of Valence Health, Inc., a health care information technology and services company, from August 2015 until the sale of the company in October 2016. Prior thereto, Mr. Eckert served as Chief Executive Officer of TriZetto Corporation, a healthcare IT solutions firm, and Chief Executive Officer of CRC Health Group, a provider of specialized behavioral healthcare services. Mr. Eckert also is the Chairman of Varian Medical Systems.Mr. Eckert is a leader in the growing field of health care information technology, with extensive experience as an executive officer of several healthcare companies. He has a deep knowledge of operations, strategic planning, product development and marketing, and has valuable corporate governance insight gained from having served as a director of several public companies.

Claire Fraser

Ms. Claire M. Fraser, Ph.D is Independent Director of the Company. She has been Director of the Institute for Genome Sciences and a Professor of Medicine at the University of Maryland School of Medicine in Baltimore, Maryland. From 1998 to 2007, she served as President and Director of The Institute for Genomic Research, a not-for-profit center dedicated to deciphering and analyzing genomes. Dr. Fraser also serves on the Board of the American Association for the Advancement of Science and the Maryland Technology Development Corporation (TEDCO).Dr. Fraser is a prominent scientist with a strong background in infectious diseases and molecular diagnostics, including the development of novel diagnostics and vaccines. She also brings considerable managerial experience in her field.

Christopher Ian Jones

Mr. Christopher Ian Jones is Independent Director of the Company. He retired in 2001 as Chief Executive Officer of JWT Worldwide (previously known as J. Walter Thompson), an international marketing firm. Since 2002, Mr. Jones has been Operating Partner and director at Motion Equity Partners, a pan-European private equity firm. He is a member of the Board of Trustees of The Pew Charitable Trusts, and a member of the Board of Directors of the Albert and Mary Lasker Foundation. He also is a director of the Cello Group, Chairman of Palmer Hargreaves, and a member of the Health Advisory Board of The Johns Hopkins University Bloomberg School of Public Health.Mr. Jones contributes an important international perspective based on his distinguished career as a marketing leader and head of a global marketing firm. He offers substantial marketing, strategic and managerial expertise derived from his broad range of activities in the field.

Marshall Larsen

Mr. Marshall O. Larsen is Independent Director of the Company. He retired in 2012 as Chairman, President and Chief Executive Officer of Goodrich Corporation, a supplier of systems and services to the aerospace and defense industry. Mr. Larsen also is a director of Air Lease Corporation, Lowe’s Companies, Inc. and United Technologies Corporation .As a veteran chief executive officer of a public company, Mr. Larsen offers the valuable perspective of an individual with highly-developed executive leadership and financial and strategic management skills in a global manufacturing company. These qualities reflect considerable domestic and international business and financial experience.

Gary Mecklenburg

Mr. Gary A. Mecklenburg is Independent Director of the Company. He retired as President and Chief Executive Officer of Northwestern Memorial HealthCare, a position he had held since 1986, and he also served as President of Northwestern Memorial Hospital from 1985 to 2002. He is currently an Executive Partner of Waud Capital Partners, L.L.C., a private equity investment firm. Mr. Mecklenburg is also a director of LHP Hospital Group, Inc. and Froedtert Health, Inc.Mr. Mecklenburg’s long tenure in hospital administration affords him a broad perspective on the many facets of the delivery of healthcare and a deep knowledge of healthcare financing and administration. As the former leader of a major teaching hospital, Mr. Mecklenburg possesses strong executive management, financial, strategic and operational knowledge as applied in a healthcare setting.

David Melcher

James Orr

Mr. James F. Orr is Independent Director of the Company. He served as Chairman of the Board of Convergys Corporation, a provider of customer management services, and which formerly also provided employee care and outsourced billing services. He also served as Convergys’ Chief Executive Officer from 1998 until his retirement in 2007. Mr. Orr is a director of Ohio National Financial Services, Inc. and Ohio National Life Insurance Company.Mr. Orr contributes the important insights of a former chief executive officer of a public company. His background reflects extensive managerial, strategic, operational and financial experience from the perspective of a service industry. He also possesses a depth of understanding of corporate governance and enterprise risk management.

Willard Overlock

Mr. Willard J. Overlock, Jr. is Independent Director of the Company. He retired in 1996 as a partner in Goldman, Sachs & Co., where he served as a member of its Management Committee, and retains the title of Senior Director to The Goldman Sachs Group, Inc. Mr. Overlock is a member of the Board of Directors of Evercore Partners, Inc., a trustee of Rockefeller University, and Chairman of the Board of Directors of the Albert and Mary Lasker Foundation. Mr. Overlock also is a member of the Board of The Cue Ball Group, LLC.Mr. Overlock has broad financial and investment banking experience based on his senior leadership roles in these areas. He contributes financial and transactional expertise and acumen in mergers and acquisitions and complex financial transactions.

Claire Pomeroy

Ms. Claire Pomeroy is Independent Director of the Company. She has served as the President of the Albert and Mary Lasker Foundation, a private foundation that seeks to improve health by accelerating support for medical research through recognition of research excellence, public education and advocacy. Prior thereto, Dr. Pomeroy served as Dean of the University of California, Davis (“UC Davis”) School of Medicine, and CEO of the UC Davis Health System. Dr. Pomeroy also is a member of the Board of Directors of Expanesthetics, Inc., and of the Sierra Health Foundation. She is a member of the Board of Trustees of the Morehouse School of Medicine and the Board of Directors of the Foundation for Biomedical ResearchDr. Pomeroy is an expert in infectious diseases, with broad experience in the area of healthcare delivery, health system administration, higher education, medical research and public health. She brings to the Board important perspectives in the areas of patient care services, global health and health policy.

Rebecca Rimel

Ms. Rebecca W. Rimel is Independent Director of the Company. She has served as President and Chief Executive Officer of The Pew Charitable Trusts, a public charity that works to improve public policy and inform the public. Ms. Rimel previously served as Assistant Professor in the Department of Neurosurgery at the University of Virginia Hospital and also as Head Nurse of its medical center emergency department. Ms. Rimel also is a director of BioTelemetry, Inc. and a director/trustee of various Deutsche mutual funds. Ms. Rimel brings executive leadership and extensive experience in public policy and advocacy, particularly in the area of healthcare. She also offers the perspective of someone with a strong background in the healthcare field.

Timothy Ring

Mr. Timothy M. Ring is Independent Director of the company. He is a Chairman and Chief Executive Officer of C.R. Bard, Inc. He was appointed a member of the Science, Marketing, Innovation and Technology Committee of the BD Board.

Bertram Scott

Mr. Bertram L. Scott is Independent Director of the Company. He is Senior Vice President of Population Health of Novant Health, an integrated network of physician practices, outpatient centers and hospitals. He previously served as President and Chief Executive Officer of Affinity Health Plan, and as President, U.S. Commercial of CIGNA Corporation. Prior thereto, Mr. Scott served as Executive Vice President of TIAA-CREF and as President and Chief Executive Officer of TIAA-CREF Life Insurance Company. Mr. Scott is a director of AXA Financial, Inc., Lowe’s Companies, Inc. and Tufts Health Plan.Mr. Scott possesses strong strategic, operational and financial experience from the variety of executive roles in which he has served during his career. He brings experience in corporate governance and business expertise in the insurance and healthcare fields.

Monique Dolecki